Literature DB >> 31536136

ISAR-REACT 5 - What have we learned?

Jacek Kubica1, Miłosz Jaguszewski2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31536136      PMCID： PMC8084390          DOI： 10.5603/CJ.a2019.0090

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  6 in total

1.  Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

Authors:  Stefanie Schüpke; Franz-Josef Neumann; Maurizio Menichelli; Katharina Mayer; Isabell Bernlochner; Jochen Wöhrle; Gert Richardt; Christoph Liebetrau; Bernhard Witzenbichler; David Antoniucci; Ibrahim Akin; Lorenz Bott-Flügel; Marcus Fischer; Ulf Landmesser; Hugo A Katus; Dirk Sibbing; Melchior Seyfarth; Marion Janisch; Duino Boncompagni; Raphaela Hilz; Wolfgang Rottbauer; Rainer Okrojek; Helge Möllmann; Willibald Hochholzer; Angela Migliorini; Salvatore Cassese; Pasquale Mollo; Erion Xhepa; Sebastian Kufner; Axel Strehle; Stefan Leggewie; Abdelhakim Allali; Gjin Ndrepepa; Helmut Schühlen; Dominick J Angiolillo; Christian W Hamm; Alexander Hapfelmeier; Ralph Tölg; Dietmar Trenk; Heribert Schunkert; Karl-Ludwig Laugwitz; Adnan Kastrati
Journal:  N Engl J Med       Date:  2019-09-01       Impact factor: 91.245

2.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Marco Valgimigli; Héctor Bueno; Robert A Byrne; Jean-Philippe Collet; Francesco Costa; Anders Jeppsson; Peter Jüni; Adnan Kastrati; Philippe Kolh; Laura Mauri; Gilles Montalescot; Franz-Josef Neumann; Mate Petricevic; Marco Roffi; Philippe Gabriel Steg; Stephan Windecker; Jose Luis Zamorano; Glenn N Levine
Journal:  Eur Heart J       Date:  2018-01-14       Impact factor: 29.983

3.  Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction.

Authors:  Aldona Kubica; Michał Kasprzak; Karolina Obońska; Tomasz Fabiszak; Ewa Laskowska; Eliano Pio Navarese; Marek Koziński; Beata Sztuba; Iwona Świątkiewicz; Grzegorz Grześk; Jacek Kubica
Journal:  Pharmacology       Date:  2015-01-15       Impact factor: 2.547

Review 4.  Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.

Authors:  Lizheng Shi; Jinan Liu; Vivian Fonseca; Philip Walker; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Health Qual Life Outcomes       Date:  2010-09-13       Impact factor: 3.186

5.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský
Journal:  Eur Heart J       Date:  2018-01-07       Impact factor: 29.983

6.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983
  6 in total
  3 in total

1.  Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines.

Authors:  Jacek Kubica; Piotr Adamski; Piotr Niezgoda; Dimitrios Alexopoulos; Jolita Badarienė; Andrzej Budaj; Katarzyna Buszko; Dariusz Dudek; Tomasz Fabiszak; Mariusz Gąsior; Robert Gil; Diana A Gorog; Stefan Grajek; Paul A Gurbel; Marcin Gruchała; Miłosz J Jaguszewski; Stefan James; Young-Hoon Jeong; Bernd Jilma; Jarosław D Kasprzak; Andrzej Kleinrok; Aldona Kubica; Wiktor Kuliczkowski; Jacek Legutko; Maciej Lesiak; Jolanta M Siller-Matula; Klaudiusz Nadolny; Krzysztof Pstrągowski; Salvatore Di Somma; Giuseppe Specchia; Janina Stępińska; Udaya S Tantry; Agnieszka Tycińska; Monica Verdoia; Wojciech Wojakowski; Eliano P Navarese
Journal:  Cardiol J       Date:  2020-10-19       Impact factor: 2.737

2.  Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022.

Authors:  Jacek Kubica; Piotr Adamski; Jerzy R Ładny; Jarosław Kaźmierczak; Tomasz Fabiszak; Krzysztof J Filipiak; Robert Gajda; Mariusz Gąsior; Zbigniew Gąsior; Robert Gil; Jarosław Gorący; Stefan Grajek; Leszek Gromadziński; Marcin Gruchała; Grzegorz Grześk; Piotr Hoffman; Miłosz J Jaguszewski; Marianna Janion; Piotr Jankowski; Zbigniew Kalarus; Jarosław D Kasprzak; Andrzej Kleinrok; Wacław Kochman; Aldona Kubica; Wiktor Kuliczkowski; Jacek Legutko; Maciej Lesiak; Klaudiusz Nadolny; Eliano P Navarese; Piotr Niezgoda; Małgorzata Ostrowska; Przemysław Paciorek; Jolanta Siller-Matula; Łukasz Szarpak; Dariusz Timler; Adam Witkowski; Wojciech Wojakowski; Andrzej Wysokiński; Marzenna Zielińska
Journal:  Cardiol J       Date:  2022-05-06       Impact factor: 3.487

3.  Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor.

Authors:  Piotr Adamski; Malwina Barańska; Małgorzata Ostrowska; Wiktor Kuliczkowski; Katarzyna Buszko; Katarzyna Kościelska-Kasprzak; Bożena Karolko; Andrzej Mysiak; Jacek Kubica
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.